Vav 1 Oncogene (VAV1) antibody
| Antigen | Vav 1 Oncogene (VAV1) |
| Synonyms | VAV, Vav, vav-T, vav1, MGC80607, VAV1 |
| Clonality | Monoclonal (3A11) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives ELISA, Immunofluorescence (IF), Western Blotting (WB) |
![]() |
5 references available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN394203 |
| Quantity | 0.1mg |
| Price | 450.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Alternative name | VAV1 |
| Gene ID | 7409 |
| Immunogen | VAV1 (AAH13361, 681 a.a. ~ 791 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 K |
| Isotype | IgG2a kappa |
| Clone | 3A11 |
| Description | Other names: VAV vav 1 oncogene |
| Characteristics | Purified Mouse Monoclonal Antibody (Mab) |
| Specificity | VAV1 (AAH13361, 681 a.a. ~ 791 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
| Molecular Weight | 98314 DA |
| Comments |
Background: The protein encoded by this proto-oncogene is a member of the Dbl family of guanine nucleotide exchange factors (GEF) for the Rho family of GTP binding proteins. The protein is important in hematopoiesis, playing a role in T-cell and B-cell development and activation. This particular GEF has been identified as the specific binding partner of Nef proteins from HIV-1. Coexpression and binding of these partners initiates profound morphological changes, cytoskeletal rearrangements and the JNK/SAPK signaling cascade, leading to increased levels of viral transcription and replication. |
Application Details
| Application Notes | ELISA ~~ 1ug/ml~3ng/ml Western blot ~~ 1:500~1000 Immunofluorescence |
| Purification | Purified |
| Buffer | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
| Storage | Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles |
| Research Area | Cell Signaling, Transcription Factors, Signaling, Cell Structure |
| Restrictions | For Research Use only |
Images
Publications
| Product |
Yu, Martins, Li et al.: "Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1." in: Cell, Vol. 140, Issue 2, pp. 246-56, 2010 (PubMed).
Kim, Das, Gross et al.: "Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase." in: Immunity, Vol. 32, Issue 2, pp. 175-86, 2010 (PubMed). Davila, Froeling, Tan et al.: "New genetic associations detected in a host response study to hepatitis B vaccine." in: Genes and immunity, Vol. 11, Issue 3, pp. 232-8, 2010 (PubMed). Barda-Saad, Shirasu, Pauker et al.: "Cooperative interactions at the SLP-76 complex are critical for actin polymerization." in: The EMBO journal, Vol. 29, Issue 14, pp. 2315-28, 2010 (PubMed). Bailey, Xie, Do et al.: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, 2010 (PubMed). |
Alternatives
Alternatives for antigen "Vav 1 Oncogene (VAV1)", type "Antibodies"




Alternatives